Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study suggests new strategies for using cell metabolism to treat cancer

Researchers at the University of Cincinnati College of Medicine have discovered that cell metabolism plays an important role in the ability of cells to start a survival program called autophagy, an unwanted side effect of some anti-cancer drugs that helps some tumor cells dodge treatment and eventually regrow into new tumors.

29 Aug 2018

Researchers develop new approach to treating cancer using enzyme therapy

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.

29 Aug 2018

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine before surgery, whether the tumor is benign or malignant.

29 Aug 2018

A non-canonical approach may improve radiation treatment for cancer

Although the success or failure of radiation therapy for cancer has long been associated with the intrinsic radio-resistance or radio-sensitivity of tumor cells, a new approach is demonstrating that radiation can take credit for an additional benefit - causing highly effective secondary immune responses that can enhance anti-tumor immunity.

28 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Experts to discuss concepts, methods of gender medicine and their impact on oncology

Gender-based approaches to studying and treating disease have remained largely unexplored in medical oncology, despite the field's growing interest in precision medicine and accumulating evidence that sex is a major factor in disease risk and response to treatment.

28 Aug 2018

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

The Medical University of South Carolina and Siemens Healthineers have formed a first-of-its-kind strategic partnership with the mutual goal of advancing the quality of health care in South Carolina.

28 Aug 2018

Researchers reveal an unlikely protector against growth of metastatic breast cancer

At the time of initial diagnosis, most patients with breast cancer show no signs that their cancer has spread elsewhere in the body. Yet, up to 30 percent of patients will ultimately experience metastasis, with breast cancer taking root and growing at other sites in the body, sometimes months, years or even decades later.

27 Aug 2018

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.

27 Aug 2018

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information.

27 Aug 2018

Insilico announces presentation of latest research at Global Precision Medicine & Biomarkers Leaders Summit

Insilico Medicine, a Rockville-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CTO, Alex Zhebrak at the 5th Global Precision Medicine & Biomarkers Leaders Summit, September 13-14, 2018, Munich, Germany.

27 Aug 2018

Evotec collaborates with CENTOGENE to develop compounds to treat rare genetic diseases

CENTOGENE today announced that Evotec AG and CENTOGENE AG entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases.

27 Aug 2018

Researchers take major step in eliminating cancer without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers.

24 Aug 2018

Researchers work to create humanized mouse model to test immunotherapies

If a new anti-cancer drug shows promise in a Petri dish, often the next step is to test the drug's effect in mice. This system tends to work well with drugs that directly target cancer, but breaks down with immunotherapies.

24 Aug 2018

Comprehensive analysis reveals weaknesses to target in common pediatric solid tumor

St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor, identifying weaknesses to target and a promising precision medicine that is now in clinical trials.

23 Aug 2018

Medical or surgical treatment for severe heartburn prevents esophageal cancer

Medical or surgical treatment of severe heartburn prevents cancer of the esophagus, a study from Karolinska Institutet with almost one million Nordic patients reveals. The results will be published in the scientific journal JAMA Oncology.

23 Aug 2018

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Bluebird bio, Inc. and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Immunotherapy combination shrinks melanoma that has spread to the brain

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial reported in the New England Journal of Medicine led by an investigator at The University of Texas MD Anderson Cancer Center.

23 Aug 2018

Penn's Radiation Oncology department provides VR mindfulness experience for patients

As your eyes scan the horizon, the starry nightscape gives way to the first hints of light as the sun peeks above the point where the ocean meets the sky. As the sun rises over the water, you glance to your right and notice a swing hanging from a tree that's lightly rocking in the gentle breeze, a breeze you can hear as it rustles leaves and calmly plays through the wind chimes on the deck of the house nearby.

22 Aug 2018

Oncology News and Research

Further Reading

Study suggests new strategies for using cell metabolism to treat cancer

Researchers develop new approach to treating cancer using enzyme therapy

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

A non-canonical approach may improve radiation treatment for cancer

Tips to know your ovarian cancer risk and symptoms

Experts to discuss concepts, methods of gender medicine and their impact on oncology

MUSC and Siemens Healthineers join hands to advance quality of health care in South Carolina

Researchers reveal an unlikely protector against growth of metastatic breast cancer

Additional inhibitor could be key to helping anti-VEGF therapies overcome resistance in glioblastoma

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

Insilico announces presentation of latest research at Global Precision Medicine & Biomarkers Leaders Summit

Evotec collaborates with CENTOGENE to develop compounds to treat rare genetic diseases

Researchers take major step in eliminating cancer without harming healthy tissue

Researchers work to create humanized mouse model to test immunotherapies

Comprehensive analysis reveals weaknesses to target in common pediatric solid tumor

Medical or surgical treatment for severe heartburn prevents esophageal cancer

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Immunotherapy combination shrinks melanoma that has spread to the brain

Penn's Radiation Oncology department provides VR mindfulness experience for patients

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News